Hindustan Foods Ltd
Hindustan Foods Limited is an India-based company, which is engaged in contract manufacturing of various FMCG products including food, home care, personal care, beverages etc. They also do manufacturing of leather shoes and accessories
- Market Cap ₹ 6,060 Cr.
- Current Price ₹ 529
- High / Low ₹ 630 / 461
- Stock P/E 65.2
- Book Value ₹ 56.4
- Dividend Yield 0.00 %
- ROCE 15.4 %
- ROE 18.2 %
- Face Value ₹ 2.00
Pros
- Company has delivered good profit growth of 50.9% CAGR over last 5 years
Cons
- Stock is trading at 9.27 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding has decreased over last quarter: -1.04%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: FMCG Industry: Food - Processing - Indian
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|
492 | 772 | 1,407 | 2,040 | 2,598 | 2,755 | |
459 | 717 | 1,319 | 1,927 | 2,425 | 2,533 | |
Operating Profit | 33 | 55 | 88 | 113 | 173 | 222 |
OPM % | 7% | 7% | 6% | 6% | 7% | 8% |
1 | 1 | 3 | 4 | 5 | 7 | |
Interest | 8 | 11 | 19 | 20 | 36 | 57 |
Depreciation | 7 | 11 | 19 | 25 | 37 | 55 |
Profit before tax | 18 | 34 | 52 | 71 | 104 | 117 |
Tax % | 35% | 35% | 29% | 38% | 32% | 21% |
12 | 22 | 37 | 45 | 71 | 93 | |
EPS in Rs | 1.76 | 2.07 | 3.52 | 3.96 | 6.31 | 8.12 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 41% |
3 Years: | 25% |
TTM: | 6% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 51% |
3 Years: | 36% |
TTM: | 31% |
Stock Price CAGR | |
---|---|
10 Years: | 53% |
5 Years: | 44% |
3 Years: | 9% |
1 Year: | -9% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 18% |
3 Years: | 19% |
Last Year: | 18% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|
Equity Capital | 13 | 21 | 21 | 23 | 23 | 23 |
Reserves | 51 | 165 | 232 | 281 | 352 | 623 |
Preference Capital | 1 | 1 | 2 | 2 | 2 | |
98 | 164 | 216 | 349 | 512 | 730 | |
104 | 189 | 267 | 332 | 449 | 549 | |
Total Liabilities | 266 | 539 | 737 | 984 | 1,335 | 1,925 |
133 | 250 | 308 | 427 | 554 | 909 | |
CWIP | 0 | 26 | 53 | 87 | 125 | 8 |
Investments | 0 | 2 | 0 | 0 | 0 | 0 |
133 | 261 | 375 | 470 | 656 | 1,008 | |
Total Assets | 266 | 539 | 737 | 984 | 1,335 | 1,925 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|
-5 | 17 | 72 | 36 | 99 | 87 | |
-40 | -145 | -90 | -139 | -220 | -381 | |
43 | 153 | 34 | 91 | 128 | 298 | |
Net Cash Flow | -2 | 24 | 16 | -12 | 7 | 3 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|
Debtor Days | 32 | 18 | 13 | 13 | 15 | 23 |
Inventory Days | 54 | 74 | 58 | 56 | 68 | 79 |
Days Payable | 84 | 94 | 74 | 64 | 69 | 68 |
Cash Conversion Cycle | 2 | -2 | -3 | 5 | 14 | 34 |
Working Capital Days | 6 | 11 | 13 | 17 | 21 | 43 |
ROCE % | 17% | 17% | 16% | 18% |
Documents
Announcements
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Concalls
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
May 2023TranscriptNotesPPT
-
Feb 2023Transcript PPT
-
Nov 2022TranscriptNotesPPT
-
Nov 2022Transcript PPT
-
Nov 2022TranscriptNotesPPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
Feb 2022TranscriptNotesPPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
May 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Aug 2020TranscriptNotesPPT
-
Jul 2020TranscriptNotesPPT
-
Jul 2020TranscriptNotesPPT
-
Feb 2020TranscriptNotesPPT
-
Nov 2019TranscriptNotesPPT
-
Aug 2019TranscriptNotesPPT
-
Aug 2019TranscriptNotesPPT
-
Mar 2018TranscriptNotesPPT
Acquired by Van group[1] Hindustan food limited (HFL) started a joint venture between Glaxo smith kline and the Dempo group to manufacture a nutritional food product under the brand name of ‘Farex’ but the venture made losses for many years as it was dependent on a single brand. In 2013, Dempo Foods Pvt. Ltd., the Holding Company of Hindustan Foods Ltd got acquired by Vanity Case India Pvt. Ltd. and the latter bought 74.45% of the paid-up share capital.